Idarucizumab for Dabigatran Reversal

Idarucizumab for Dabigatran Reversal
Jul 16, 2015 1:01pm

Melissa Thomas at Boehringer Ingelheim sent a press release about the report of their phase III trial, Idarucizumab for Dabigatran Reversal. The free full text article, Pollack CV, Reliiy PA, Eikelboom J, et al. Idarucizumab for dabigatran reversal, NEJM 2015, DOI: 10.1056/NEJMoa1502000, is available from the NEJM web site.

0 Comments

Leave A Comment

You must be logged in to Comment - Sign In